Outcomes of octogenarians undergoing holmium laser enucleation of prostate

Joshua Heiman*, Deepak Agarwal, Sarah Komanapalli, Charles Nottingham, Tim Large, Amy Krambeck, Marcelino Rivera

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

13 Scopus citations


Purpose: Holmium laser enucleation of prostate (HoLEP) is an effective surgical procedure in men with BPH. Due to the increase in the use of medical therapy for BPH related lower urinary symptoms more octogenarians are presenting in a delayed fashion with significant symptoms and urinary retention. We evaluate the feasibility and safety of octogenarians undergoing HoLEP. Methods: We performed a retrospective review of HoLEPs at our institution from July 2018 to December 2019. Patients were stratified into two groups based on age: < 80 and ≥ 80. Results: A total of 458 patients were identified, with 74 (16.2%) ≥ 80. In patients ≥ 80, prostate volume was higher (p < 0.0005), there was a higher rate of antiplatelet/anticoagulation (p = 0.029) use, and a lower rate of alpha-blocker use (p = 0.0016). As expected, ASA scores which correlate with increasing number of concomitant diseases were greater in the ≥ 80 cohort (p = 0.016). There was no significant difference in intraoperative complications (p = 0.14), 90 day complication (p = 0.34), readmission rates (p = 0.425) or emergency room visits between groups (p = 0.15). Conclusions: Despite higher medical comorbidities and increased rates of anticoagulation in octogenarians, there is no increase in operative or postoperative complication rates. Age alone should not be used as exclusion criteria for HoLEP.

Original languageEnglish (US)
JournalWorld journal of urology
StateAccepted/In press - 2022


  • BPH
  • HoLEP
  • Octogenarian
  • Surgery

ASJC Scopus subject areas

  • Urology


Dive into the research topics of 'Outcomes of octogenarians undergoing holmium laser enucleation of prostate'. Together they form a unique fingerprint.

Cite this